Physician
Aw Pathology Medical Group, INC.
Aw Pathology Medical Group, INC. was paid $2.05M by Medicaid between Jan 2018 and Nov 2024, across 88 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.
33Billing provider infoAW PATHOLOGY MEDICAL GROUP, INC.
BAKERSFIELD, CA 93301
BAKERSFIELD, CA 93301
33aNPI1972534147assigned 07/06/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$2.05M
24GClaims952,307
24DCodes billed88
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#23 of 222
Median peer was paid$42K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 80,472 | $120K | |
| 2019 | 110,921 | $196K | |
| 2020 | 121,727 | $282K | |
| 2021 | 179,235 | $393K | |
| 2022 | 131,524 | $332K | |
| 2023 | 173,264 | $396K | |
| 2024incomplete | 155,164 | $337K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 14% | 130,815 | 99,779 | $284K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 14% | 6,560 | 6,375 | $278K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11% | 181,473 | 116,468 | $229K |
| 88307 | 10% | 2,664 | 2,650 | $206K | |
| 83880 | 4.6% | 17,463 | 12,029 | $95K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.0% | 53,401 | 25,922 | $81K |
| 84484 | 3.7% | 42,885 | 37,297 | $77K | |
| 83735 | 3.4% | 56,199 | 19,676 | $70K | |
| 88304 | 3.4% | 3,095 | 3,089 | $69K | |
| 83690 | 2.9% | 52,764 | 46,148 | $61K | |
| 88312 | 2.9% | 2,772 | 2,764 | $60K | |
| 84145 | 2.3% | 11,510 | 6,820 | $47K |
76 more codes
| 83605 | 2.1% | 25,308 | $44K | |
| 81001 | 2.0% | 57,190 | $41K | |
| 82803 | 1.9% | 12,636 | $40K | |
| 85730 | 1.3% | 23,510 | $27K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 1,840 | $26K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 1,158 | $26K |
| 84100 | 1.1% | 27,293 | $23K | |
| 85610 | 1.0% | 28,405 | $21K | |
| 85379 | <1% | 9,312 | $16K | |
| 85027 | <1% | 13,087 | $14K | |
| 80202 | <1% | 6,046 | $14K | |
| 81003 | <1% | 28,527 | $13K | |
| 82962 | <1% | 8,641 | $11K | |
| 80076 | <1% | 8,537 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,892 | $10K |
| 86901 | <1% | 18,066 | $9K | |
| 82140 | <1% | 2,770 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,844 | $9K |
| 82010 | <1% | 4,112 | $8K | |
| 82550 | <1% | 5,392 | $8K | |
| 86920 | <1% | 1,827 | $7K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,342 | $7K |
| 86900 | <1% | 14,457 | $7K | |
| 87631 | <1% | 569 | $7K | |
| 86140 | <1% | 7,822 | $7K | |
| 80061 | Lipid panel | <1% | 2,580 | $6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 990 | $6K |
| 86850 | <1% | 10,089 | $5K | |
| 84702 | <1% | 2,858 | $5K | |
| 88108 | <1% | 174 | $5K | |
| 84703 | <1% | 6,528 | $4K | |
| 81025 | <1% | 6,527 | $4K | |
| 87205 | <1% | 4,324 | $4K | |
| 86592 | <1% | 4,473 | $3K | |
| 85384 | <1% | 1,839 | $3K | |
| 85007 | <1% | 4,126 | $3K | |
| 85651 | <1% | 4,127 | $3K | |
| 86703 | <1% | 1,269 | $3K | |
| 88313 | <1% | 166 | $3K | |
| 83615 | <1% | 2,556 | $3K | |
| 80050 | General health panel | <1% | 360 | $2K |
| 86880 | <1% | 2,268 | $2K | |
| 88311 | <1% | 469 | $2K | |
| 84439 | <1% | 1,191 | $2K | |
| 87040 | <1% | 779 | $2K | |
| P9011 | Blood, split unit | <1% | 3,247 | $2K |
| 82570 | <1% | 1,393 | $1K | |
| 82272 | <1% | 941 | $1K | |
| 89051 | <1% | 308 | $1K | |
| 87210 | <1% | 1,751 | $1K | |
| 84550 | <1% | 1,561 | $1K | |
| 82150 | <1% | 893 | $967.91 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 560 | $905.01 |
| 84156 | <1% | 1,265 | $764.68 | |
| 84478 | <1% | 888 | $704.42 | |
| 84157 | <1% | 365 | $204.00 | |
| 82728 | <1% | 136 | $182.80 | |
| 84466 | <1% | 71 | $135.22 | |
| 83930 | <1% | 110 | $123.46 | |
| 80305 | <1% | 81 | $121.09 | |
| 80069 | <1% | 56 | $85.12 | |
| 82375 | <1% | 38 | $81.86 | |
| 82945 | <1% | 122 | $79.83 | |
| 84300 | <1% | 100 | $78.48 | |
| 83540 | <1% | 73 | $72.81 | |
| 87324 | <1% | 27 | $60.93 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 50 | $60.21 |
| 87420 | <1% | 83 | $58.07 | |
| 83050 | <1% | 38 | $47.72 | |
| 85018 | <1% | 91 | $28.03 | |
| 86308 | <1% | 28 | $20.39 | |
| 85014 | <1% | 89 | $17.56 | |
| 87070 | <1% | 12 | $14.90 | |
| 84105 | <1% | 14 | $12.88 | |
| 81015 | <1% | 26 | $12.35 | |
| 84112 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWU, AGNES (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Aw Cytohistology Lab | Bakersfield, CA | $403.13 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.